XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument 7N6 GI000A2PX455 WISHBONE GOLD PLC LS-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument 7N6 GI000A2PX455 WISHBONE GOLD PLC LS-,001 EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument 4BD0 NO0012953720 HUNTER GROUP NK 0,0382367 EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument 4BD0 NO0012953720 HUNTER GROUP NK 0,0382367 EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument MR9 KYG609201085 MIDEA REAL HLDG HD 1 EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument MR9 KYG609201085 MIDEA REAL HLDG HD 1 EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument MOL US60855D3098 MOLECULIN BIOTECH DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument MOL US60855D3098 MOLECULIN BIOTECH DL-,001 EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument 24P ZAE000156253 CURRO HLDGS LTD RC-,00001 EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument 24P ZAE000156253 CURRO HLDGS LTD RC-,00001 EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument 7AL0 SE0024173637 ALLIGATOR BIOSC. AB O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument 7AL0 SE0024173637 ALLIGATOR BIOSC. AB O.N. EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument YBB AU000000CAV5 CARNAVALE RESOURCES LTD EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument YBB AU000000CAV5 CARNAVALE RESOURCES LTD EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument MLN CA60283T2074 MINERAL HILL INDUSTR.NEW EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument MLN CA60283T2074 MINERAL HILL INDUSTR.NEW EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Das Instrument G4P0 CA55082H2063 LYCOS ENERGY INC. NEW EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025
The instrument G4P0 CA55082H2063 LYCOS ENERGY INC. NEW EQUITY is traded cum capital adjustment on 28.11.2025 and ex capital adjustment on 01.12.2025

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
Di	Bulletin from The Extraordinary General Meeting in Alligator Bioscience AB	LUND, SE / ACCESS Newswire / November 25, 2025 / Alligator Bioscience (STO:ATORX) - Today, on 25 November 2025, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the... ► Artikel lesen
Mo	Alligator Bioscience AB: Alligator Bioscience announces final terms of rights issue	NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen
05.11.	Alligator Bioscience Presents New Data on Mitazalimab and ATOR-4066 at SITC 40th Anniversary Annual Meeting	LUND, SE / ACCESS Newswire / November 5, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today... ► Artikel lesen
03.11.	Nomination Committee Appointed in Respect of AGM 2026 in Alligator Bioscience AB	LUND, SWEDEN / ACCESS Newswire / November 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

Bulletin from The Extraordinary General Meeting in Alligator Bioscience AB

LUND, SE / ACCESS Newswire / November 25, 2025 / Alligator Bioscience (STO:ATORX) - Today, on 25 November 2025, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the...
► Artikel lesen

Alligator Bioscience AB: Alligator Bioscience announces final terms of rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen

05.11.

Alligator Bioscience Presents New Data on Mitazalimab and ATOR-4066 at SITC 40th Anniversary Annual Meeting

LUND, SE / ACCESS Newswire / November 5, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today...
► Artikel lesen

03.11.

Nomination Committee Appointed in Respect of AGM 2026 in Alligator Bioscience AB

LUND, SWEDEN / ACCESS Newswire / November 3, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
Do	Reverse split and Change of ISIN for Biosergen AB	The company will carry out a reverse stock split in a ratio of 1:100. The share will be traded under new ISIN code with effect from Dec 1, 2025. The order book will not change. Short... ► Artikel lesen
20.11.	Biosergen AB: Determination of Record Date for Reverse Share Split in Biosergen	STOCKHOLM, November 20, 2025. At the Annual General Meeting of Biosergen AB ("Biosergen" or the "Company") on June 11, 2025, a resolution was passed on a reverse split of shares, whereby one hundred... ► Artikel lesen
19.11.	Biosergen AB: Biosergen publishes interim report for the third quarter 2025	November 19, 2024: Biosergen AB ("Biosergen" or the "Company") hereby publishes the interim report for the third quarter 2025. The interim report is available as an attached document and on the company... ► Artikel lesen
28.10.	BIOSERGEN AB: Biosergen's Nomination Committee appointed

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

Reverse split and Change of ISIN for Biosergen AB

The company will carry out a reverse stock split in a ratio of 1:100. The share will be traded under new ISIN code with effect from Dec 1, 2025. The order book will not change. Short...
► Artikel lesen

20.11.

Biosergen AB: Determination of Record Date for Reverse Share Split in Biosergen

STOCKHOLM, November 20, 2025. At the Annual General Meeting of Biosergen AB ("Biosergen" or the "Company") on June 11, 2025, a resolution was passed on a reverse split of shares, whereby one hundred...
► Artikel lesen

19.11.

Biosergen AB: Biosergen publishes interim report for the third quarter 2025

November 19, 2024: Biosergen AB ("Biosergen" or the "Company") hereby publishes the interim report for the third quarter 2025. The interim report is available as an attached document and on the company...
► Artikel lesen

28.10.

BIOSERGEN AB: Biosergen's Nomination Committee appointed

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
01:16	CARNAVALE RESOURCES LIMITED: Investor Presentation
Do	CARNAVALE RESOURCES LIMITED: Results of Meeting and Consolidation Update
11.11.	CARNAVALE RESOURCES LIMITED: Consolidation/Split - CAV
10.11.	CARNAVALE RESOURCES LIMITED: Change of Director's Interest Notice x 3

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

01:16

CARNAVALE RESOURCES LIMITED: Investor Presentation

CARNAVALE RESOURCES LIMITED: Results of Meeting and Consolidation Update

11.11.

CARNAVALE RESOURCES LIMITED: Consolidation/Split - CAV

10.11.

CARNAVALE RESOURCES LIMITED: Change of Director's Interest Notice x 3

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
13.11.	CURRO HOLDINGS LIMITED - Further Transaction Update Announcement
04.11.	CURRO HOLDINGS LIMITED - Voluntary Announcement - Disclosure of Disposal of Securities
31.10.	CURRO HOLDINGS LIMITED - Results of the General Meeting and Further Transaction Update
30.10.	CURRO HOLDINGS LIMITED - Further Transaction Update Announcement

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

13.11.

CURRO HOLDINGS LIMITED - Further Transaction Update Announcement

04.11.

CURRO HOLDINGS LIMITED - Voluntary Announcement - Disclosure of Disposal of Securities

31.10.

CURRO HOLDINGS LIMITED - Results of the General Meeting and Further Transaction Update

30.10.

CURRO HOLDINGS LIMITED - Further Transaction Update Announcement

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
Do	XFRA MLN: AUSSETZUNG/SUSPENSION	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMINERAL HILL INDUSTR.NEW... ► Artikel lesen
Di	Mineral Hill Industries Ltd. führt Namensänderung durch
Di	Mineral Hill Industries Ltd. To Change Name To Gold Strategy Inc.	VANCOUVER, BC, Nov. 25, 2025 /PRNewswire/ - Mineral Hill Industries Ltd. (TSXV: MHI) (the "Company") announces that it will change its name to "Gold Strategy Inc." Effective... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

XFRA MLN: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMINERAL HILL INDUSTR.NEW...
► Artikel lesen

Mineral Hill Industries Ltd. führt Namensänderung durch

Mineral Hill Industries Ltd. To Change Name To Gold Strategy Inc.

VANCOUVER, BC, Nov. 25, 2025 /PRNewswire/ - Mineral Hill Industries Ltd. (TSXV: MHI) (the "Company") announces that it will change its name to "Gold Strategy Inc." Effective...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
Do	Hunter Group ASA - Key information relating to the cash dividend
Do	Hunter Group ASA - NOK 0.30 dividend
Do	Hunter Group ASA - Third quarter results 2025
15.09.	Hunter Group ASA - PDMR notification

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

Hunter Group ASA - Key information relating to the cash dividend

Hunter Group ASA - NOK 0.30 dividend

Hunter Group ASA - Third quarter results 2025

15.09.

Hunter Group ASA - PDMR notification

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
19.11.	Lycos Energy GAAP EPS of C$0.05
19.11.	Lycos Energy Inc. Announces Third Quarter Financial Results and Operations Update	Calgary, Alberta--(Newsfile Corp. - November 18, 2025) - Lycos Energy Inc. (TSXV: LCX) ("Lycos" or the "Company") is pleased to announce its operating and financial results for the three and nine months... ► Artikel lesen
18.11.	Lycos Energy Inc (2): Lycos to pay 90-cent special distribution Nov. 28
14.11.	Lycos Energy declares CAD 0.90 dividend

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

19.11.

Lycos Energy GAAP EPS of C$0.05

19.11.

Lycos Energy Inc. Announces Third Quarter Financial Results and Operations Update

Calgary, Alberta--(Newsfile Corp. - November 18, 2025) - Lycos Energy Inc. (TSXV: LCX) ("Lycos" or the "Company") is pleased to announce its operating and financial results for the three and nine months...
► Artikel lesen

18.11.

Lycos Energy Inc (2): Lycos to pay 90-cent special distribution Nov. 28

14.11.

Lycos Energy declares CAD 0.90 dividend

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
27.10.	MIDEA REAL EST (03990): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
27.10.	MIDEA REAL EST (03990): RE-DESIGNATION OF DIRECTOR, CHANGES IN AUTHORISED REPRESENTATIVE AND COMPOSITION OF BOARD COMMITTEES
27.10.	MIDEA REAL EST (03990): AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
27.10.	MIDEA REAL EST (03990): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 27 OCTOBER 2025

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

27.10.

MIDEA REAL EST (03990): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

27.10.

MIDEA REAL EST (03990): RE-DESIGNATION OF DIRECTOR, CHANGES IN AUTHORISED REPRESENTATIVE AND COMPOSITION OF BOARD COMMITTEES

27.10.

MIDEA REAL EST (03990): AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

27.10.

MIDEA REAL EST (03990): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 27 OCTOBER 2025

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
Mi	Moleculin Biotech, Inc.: Moleculin to Participate in the Virtual Investor Closing Bell Series
Mi	Moleculin Biotech announces 1-for-25 reverse stock split
Mi	Moleculin to execute 1-for-25 reverse stock split
Mi	Moleculin Biotech, Inc.: Moleculin Announces Reverse Stock Split	HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), today announced that it filed an amendment to its amended and restated certificate... ► Artikel lesen

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

Moleculin Biotech, Inc.: Moleculin to Participate in the Virtual Investor Closing Bell Series

Moleculin Biotech announces 1-for-25 reverse stock split

Moleculin to execute 1-for-25 reverse stock split

Moleculin Biotech, Inc.: Moleculin Announces Reverse Stock Split

HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), today announced that it filed an amendment to its amended and restated certificate...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06:00	XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025	Das Instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY wird cum Kapitalmassnahme gehandelt am 28.11.2025 und ex Kapitalmassnahme am 01.12.2025 The instrument 8N1 SE0016013460 BIOSERGEN AB EQUITY is traded... ► Artikel lesen
18.11.	Wishbone Gold PLC - General Meetings, Share Consolidation and TVR
13.11.	Wishbone Gold reports 3km gold mineralisation strike at Red Setter
13.11.	Wishbone Gold PLC - Mineralisation over 3km strike at Red Setter
07.11.	Wishbone Gold PLC - Notice of AGM and EGM

Zeit

Aktuelle Nachrichten

06:00

XFRA CAPITAL ADJUSTMENT INFORMATION - 28.11.2025

18.11.

Wishbone Gold PLC - General Meetings, Share Consolidation and TVR

13.11.

Wishbone Gold reports 3km gold mineralisation strike at Red Setter

13.11.

Wishbone Gold PLC - Mineralisation over 3km strike at Red Setter

07.11.

Wishbone Gold PLC - Notice of AGM and EGM

Unternehmen / Aktien	Kurs	%
ALLIGATOR BIOSCIENCE AB	0,062	+15,83 %
BIOSERGEN AB	0,035	-11,62 %
CARNAVALE RESOURCES LIMITED	0,002	-40,00 %
CURRO HOLDINGS LIMITED	0,655	-0,76 %
GOLD STRATEGY INC	0,045	0,00 %
HUNTER GROUP ASA	0,181	+1,80 %
LYCOS ENERGY INC	0,860	0,00 %
MIDEA REAL ESTATE HOLDING LTD	0,486	-1,10 %
MOLECULIN BIOTECH INC	0,510	-100,00 %
WISHBONE GOLD PLC	0,001	0,00 %

Unternehmen / Aktien

Kurs

ALLIGATOR BIOSCIENCE AB

0,062

+15,83 %

BIOSERGEN AB

0,035

-11,62 %

CARNAVALE RESOURCES LIMITED

0,002

-40,00 %

CURRO HOLDINGS LIMITED